Philips settles one category of U.S. claims over respirator recall

Philips settles one category of U.S. claims related to recall of sleep apnea devices
Will make initial $479 million payment to fund for claimants covered by settlement
Had taken $615 million provision for estimated costs of economic loss claims
Still faces other legal actions over recall, including personal injury claims
In talks with FDA over potential consent decree or settlement
Lawyers say will continue pursuing personal injury and other claims against Philips

reuters.com

Relevant topic timeline:

9/7/2023

CPAP Maker Reaches $479 Million Settlement on Breathing Device Defects

CPAP manufacturer Philips Respironics has reached a $479 million settlement to compensate users of its breathing machines and vendors impacted by the devices' defects, which included blowing bits of foam into consumers' mouths and lungs.